Brainstorm Cell Therapeutics | BCLI - Ebitda

Aktienkurs
0.92
Täglich Wechseln
0.01 1.43%
Monatlich
24.73%
Jährlich
21.07%
Q2 Prognose
0.90




Ebitda Veränderung Datum
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Biogen USD 573.2M 253.7M 2025-12
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Mesoblast USD -20.3M 2.51M 2025-12